SE390412B - 2,4-diamino-5-(4'-hydroxybensyl)pyrimidiner till anvendning, som utgangsmaterial for framstellning av 2,4-diamino-5-(3',4',5'-trialikocibensyl)pyrimidiner - Google Patents

2,4-diamino-5-(4'-hydroxybensyl)pyrimidiner till anvendning, som utgangsmaterial for framstellning av 2,4-diamino-5-(3',4',5'-trialikocibensyl)pyrimidiner

Info

Publication number
SE390412B
SE390412B SE796270A SE796270A SE390412B SE 390412 B SE390412 B SE 390412B SE 796270 A SE796270 A SE 796270A SE 796270 A SE796270 A SE 796270A SE 390412 B SE390412 B SE 390412B
Authority
SE
Sweden
Prior art keywords
pyrimidines
diamino
trialicocibensyl
hydroxybenzyl
preparation
Prior art date
Application number
SE796270A
Other languages
English (en)
Swedish (sv)
Inventor
V B Roth
J Z Strelitz
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SE390412B publication Critical patent/SE390412B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50Three nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
SE796270A 1966-02-19 1967-02-20 2,4-diamino-5-(4'-hydroxybensyl)pyrimidiner till anvendning, som utgangsmaterial for framstellning av 2,4-diamino-5-(3',4',5'-trialikocibensyl)pyrimidiner SE390412B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB737666A GB1128234A (en) 1966-02-19 1966-02-19 5-benzylpyrimidine derivatives and process for the preparation thereof

Publications (1)

Publication Number Publication Date
SE390412B true SE390412B (sv) 1976-12-20

Family

ID=9831956

Family Applications (2)

Application Number Title Priority Date Filing Date
SE796270A SE390412B (sv) 1966-02-19 1967-02-20 2,4-diamino-5-(4'-hydroxybensyl)pyrimidiner till anvendning, som utgangsmaterial for framstellning av 2,4-diamino-5-(3',4',5'-trialikocibensyl)pyrimidiner
SE227867A SE338998B (xx) 1966-02-19 1967-02-20

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE227867A SE338998B (xx) 1966-02-19 1967-02-20

Country Status (16)

Country Link
AT (2) AT275534B (xx)
BE (1) BE694244A (xx)
CA (1) CA977754A (xx)
CH (2) CH511239A (xx)
DE (2) DE1795635C3 (xx)
DK (2) DK120344B (xx)
ES (1) ES336945A1 (xx)
FI (1) FI49714C (xx)
FR (1) FR6595M (xx)
GB (1) GB1128234A (xx)
GR (1) GR33641B (xx)
IL (1) IL27424A (xx)
MY (1) MY7100226A (xx)
NL (1) NL146811B (xx)
NO (1) NO124601B (xx)
SE (2) SE390412B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE789904A (fr) * 1971-10-12 1973-04-10 Wellcome Found Procedes de synthese organique
JPS54154775A (en) * 1978-05-24 1979-12-06 Wellcome Found Benzylpyrimidine derivative
DE2944145A1 (de) 1979-11-02 1981-05-14 Dynamit Nobel Ag, 5210 Troisdorf Verfahren zur herstellung von 2,4-diaminopyrimidin

Also Published As

Publication number Publication date
NL146811B (nl) 1975-08-15
CH513179A (de) 1971-09-30
AT275534B (de) 1969-10-27
DE1720012A1 (de) 1972-04-06
NL6702397A (xx) 1967-08-21
SE338998B (xx) 1971-09-27
DK128247B (da) 1974-03-25
FI49714C (fi) 1975-09-10
DE1795635C3 (de) 1978-05-11
AT270653B (de) 1969-05-12
GB1128234A (en) 1968-09-25
FI49714B (xx) 1975-06-02
FR6595M (xx) 1969-01-06
DK120344B (da) 1971-05-17
CH511239A (de) 1971-08-15
GR33641B (el) 1968-01-03
CA977754A (en) 1975-11-11
DE1795635B2 (de) 1977-09-22
ES336945A1 (es) 1968-01-16
DE1720012B2 (de) 1977-06-08
BE694244A (xx) 1967-08-17
MY7100226A (en) 1971-12-31
IL27424A (en) 1971-02-25
DE1795635A1 (de) 1972-10-19
NO124601B (xx) 1972-05-08

Similar Documents

Publication Publication Date Title
IL24534A (en) Manufacture of 2,4-diamino pyrimidine derivatives
SE390969B (sv) Forfarande for framstellning av 1,2,3,4-tetrahydro-7-halogen-6-sulfamyl-4-kinazolinoner
DK118460B (da) Analogifremgangsmåde til fremstilling af sulfonylurinstofderivater.
DK118561B (da) Analogifremgangsmåde til fremstilling af o-(2',3',5',6'-tetrafluoranilino)-5-phenyl-1,3,4-oxadiozol-2-on.
SE390412B (sv) 2,4-diamino-5-(4'-hydroxybensyl)pyrimidiner till anvendning, som utgangsmaterial for framstellning av 2,4-diamino-5-(3',4',5'-trialikocibensyl)pyrimidiner
DK114767B (da) Analogifremgangsmåde til fremstilling af 1,1-diphenyl-2-methyl-3-(benzylidenamino)propanoler.
DK116363B (da) Fremgangsmåde til fremstilling af N,N'-disubstituerede piperazinderivater.
DK131429B (da) Analogifremgangsmåde til fremstilling af derivater af 4'-demethyl-epipodophyllotoxin-beta-D-glucosid.
SE413506B (sv) 2,4-diaminopyrimidinforeningar till anvendning som utgangsmaterial for framstellning av 2,4-diamino-5-bensylpyrimidiner
SE397086B (sv) 3-cyancyklopentenonderivat till anvendning som utgangsmaterial for framstellning av 3-hydroxialkenylcyklopentan-1,4-diolderivat samt forfarande for framstellning av 3-cyancyklopentenonderivatet
DK115617B (da) Fremgangsmåde til fremstilling af 2,2-dichlor-1,1,3,3-tetrafluorpropan.
DK116656B (da) Analogifremgangsmåde til fremstilling af 11-oxygenerede 3-(2'-chlorethylthio)-6-formyl-9α-fluor-3,5-pregnadien-20-oner.
DK114972B (da) Fremgangsmåde til fremstilling af 4-halogen-1,2α; 6,7β-bismethylen-Δ<4>-3-ketosteroider.
DK117961B (da) Analogifremgangsmåde til fremstilling af guanidinderivater.
DK116357B (da) Fremgangsmåde til fremstilling af 1,1,1,2,2-pentafluor-3-chlorpropan.
DK120347B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepin-4-oxider.
DK120849B (da) Analogifremgangsmåde til fremstilling af derivater af 4'-demethylepipodophyllotoxin-β-D-glucosid.
DK118406B (da) Fremgangsmåde til fremstilling af 3-alkynyloxy- og 3-alkenyloxy-4-sulfanilamido-1,2,5-thiadiazoler.
DK120131B (da) Fremgangsmåde til fremstilling af 3-oxo-13β-alkylgona-4,9,11-triener.
DK115622B (da) Fremgangsmåde til fremstilling af 3-oxogona-4,9,11-triener.
DK114962B (da) Fremgangsmåde til fremstilling af α, α, α', α'-tetramethyl-xylylen-dicarbinoler.
SE380531B (sv) Forfarande for framstellning av 13-alkyl-1,3,5(10),6,8,14-steroidhexaener
DK119555B (da) Fremgangsmåde til fremstilling af 37β-hydroxy-Δ<4>-androsten- eller -ostrenderivater.
DK120845B (da) Fremgangsmåde til fremstilling af 3β-formoxy-15α-halogen-14β-hydroxy-5β-card-20(22)-enolider.
FI48592C (fi) Menetelmä bakteereja tuhoavien N-alkoksiasetyyli-N1-3-isoksatsoli-sulf aniiliamidien valmistamiseksi.